Novel ‘hydrogel’ carriers for anti-cancer drugs offer new hope for cancer treatment

Clinical trial completion rates decline during COVID-19 pandemic
7 April 2021
Covid-19, open science, and the CVD-COVID-UK initiative
8 April 2021

Novel ‘hydrogel’ carriers for anti-cancer drugs offer new hope for cancer treatment

Cancer therapy in recent times relies on the use of several drugs derived from biological sources including different bacteria and viruses, among others. However, these bio-based drugs get easily degraded and therefore inactivated on administration into the body. Thus, effective delivery to and release of these drugs at target tumor sites are of paramount importance from the perspective of cancer therapy.

Comments are closed.